ZA200502790B - Extract with anti-tumor and anti-poisonous activity. - Google Patents

Extract with anti-tumor and anti-poisonous activity.

Info

Publication number
ZA200502790B
ZA200502790B ZA200502790A ZA200502790A ZA200502790B ZA 200502790 B ZA200502790 B ZA 200502790B ZA 200502790 A ZA200502790 A ZA 200502790A ZA 200502790 A ZA200502790 A ZA 200502790A ZA 200502790 B ZA200502790 B ZA 200502790B
Authority
ZA
South Africa
Prior art keywords
extracts
tumor
extract
activity
poisonous
Prior art date
Application number
ZA200502790A
Other languages
English (en)
Inventor
Francis Darro
Jean-Claude Braekman
Pierre Guissou
Odile Germaine Nacoulma
Mohamed El Yazidi
Janique Dewelle
Rob Van Ginkel
Marc Van Damme
Robert Kiss
Original Assignee
Unibioscreen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unibioscreen Sa filed Critical Unibioscreen Sa
Publication of ZA200502790B publication Critical patent/ZA200502790B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/27Asclepiadaceae (Milkweed family), e.g. hoya
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200502790A 2002-10-09 2005-04-06 Extract with anti-tumor and anti-poisonous activity. ZA200502790B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/011310 WO2004032947A1 (en) 2002-10-09 2002-10-09 Extract with anti-tumor and anti-poisonous activity

Publications (1)

Publication Number Publication Date
ZA200502790B true ZA200502790B (en) 2006-02-22

Family

ID=32087933

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200502790A ZA200502790B (en) 2002-10-09 2005-04-06 Extract with anti-tumor and anti-poisonous activity.

Country Status (15)

Country Link
US (1) US20060057237A1 (ja)
EP (1) EP1549329B1 (ja)
JP (1) JP4944380B2 (ja)
CN (1) CN100522184C (ja)
AT (1) ATE349221T1 (ja)
AU (2) AU2002342808A1 (ja)
CA (1) CA2501240A1 (ja)
DE (1) DE60310742T2 (ja)
DK (1) DK1549329T3 (ja)
ES (1) ES2279157T3 (ja)
HK (1) HK1082663A1 (ja)
MX (1) MXPA05003634A (ja)
PT (1) PT1549329E (ja)
WO (2) WO2004032947A1 (ja)
ZA (1) ZA200502790B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1755627A1 (en) * 2004-04-19 2007-02-28 All India Institute of Medical Sciences Extracts of latex of calotropis procera and to a method of preparation thereof
CN101647790B (zh) * 2006-11-23 2011-10-26 樊献俄 三十烷醇在制备抗癌药物中的应用
CN101190210B (zh) * 2006-11-23 2010-05-12 樊献俄 三十烷醇在制备抗癌药物中的应用
CN101391998B (zh) * 2008-09-25 2012-07-04 成都普思生物科技有限公司 一种喜树碱的高效分离纯化方法
MY179036A (en) 2012-12-13 2020-10-26 Malaysian Palm Oil Board Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
CN104398532B (zh) * 2013-04-11 2017-02-22 中国热带农业科学院热带作物品种资源研究所 一种强心苷化合物的用途
US9533019B1 (en) * 2016-03-02 2017-01-03 King Saud University Calotropis procera extracts as anti-ulcerative colitis agents
IL256648A (en) 2017-12-28 2018-02-28 Ahava Dead Sea Laboratories Ltd Cosmetic preparations containing Sodom apple extract
US10111918B1 (en) 2018-03-02 2018-10-30 King Saud University Method of preparing biologically active derivatives from Calotropis gigantea flowers
CN111214478B (zh) * 2020-02-24 2023-08-08 海南医学院 弗如糖苷在制备治疗和/或预防滑膜相关疾病的药物中的用途
CN112194703B (zh) * 2020-09-03 2021-08-03 澳门科技大学 一种强心苷类化合物及其合成方法与应用
CN114831997A (zh) * 2022-06-07 2022-08-02 南昌大学第一附属医院 抑制结直肠癌细胞增殖药物及蒲公英甾醇的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
EP0641193A4 (en) * 1992-05-20 1995-09-06 Daniel S Martin CHEMOTHERAPEUTIC DRUG COMBINATIONS.
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9710698D0 (en) * 1997-05-24 1997-07-16 Verkaik Margaretha S E Composition
US8029561B1 (en) * 2000-05-12 2011-10-04 Cordis Corporation Drug combination useful for prevention of restenosis
EP1351573A4 (en) * 2000-12-22 2007-03-28 Bristol Myers Squibb Co METHOD FOR MODULATING TUMOR WATCHTOWER AND METASTASIS

Also Published As

Publication number Publication date
DE60310742D1 (de) 2007-02-08
WO2004032947A1 (en) 2004-04-22
US20060057237A1 (en) 2006-03-16
PT1549329E (pt) 2007-03-30
AU2003273973B2 (en) 2008-11-20
DK1549329T3 (da) 2007-05-07
AU2002342808A1 (en) 2004-05-04
JP2006503872A (ja) 2006-02-02
JP4944380B2 (ja) 2012-05-30
ATE349221T1 (de) 2007-01-15
HK1082663A1 (en) 2006-06-16
WO2004032948A1 (en) 2004-04-22
EP1549329B1 (en) 2006-12-27
CN1711099A (zh) 2005-12-21
MXPA05003634A (es) 2005-12-14
DE60310742T2 (de) 2007-10-11
CN100522184C (zh) 2009-08-05
EP1549329A1 (en) 2005-07-06
ES2279157T3 (es) 2007-08-16
CA2501240A1 (en) 2004-04-22
AU2003273973A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
HK1082663A1 (en) Extract with anti-tumor and anti-poisonous activity
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
YU44404A (sh) Postupak za identifikovanje ciljnih enzima tumora
MX2007007458A (es) Derivados de quinazolina para inhibir crecimiento de celulas cancerigenas y metodo para la preparacion de los mismos.
AU7031500A (en) Therapeutic quinazoline compounds
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
GB0222514D0 (en) Organic compounds
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
AU4258101A (en) Combination therapies with vascular damaging activity
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
HK1040983A1 (en) Quinones for treatment of diseases.
WO2003000203A3 (en) Chlorotoxin inhibition of cell invasion, cancer metastasis, angiogenesis and tissue remodeling
GB9907571D0 (en) Compounds
IL166596A0 (en) Salt of morphine-6-glucoronide
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
WO2005081972A3 (en) Maleiimide anti-tumor phosphatase inhibitors
MY133682A (en) Substituted pyrroles
WO2004071398A3 (en) Pharmaceutical patch
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
GB0326518D0 (en) Anti-cancer compounds
WO2004064748A3 (en) Compositions and methods for treatment of ovarian cancer
MXPA05006378A (es) Compuestos esteroides con actividad anti-tumoral.